IPILIMUMAB

Overview

IPILIMUMAB is a Schedule H drug.
Ipilimumab is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Ipilimumab is used to treat melanoma (skin cancer) that cannot be treated with surgery or has spread to other parts of the body. Ipilimumab is also used to prevent melanoma from coming back after surgery, including lymph node removal. Ipilimumab is also used to treat kidney cancer, sometimes given with another medicine called nivolumab.

Usage

IPILIMUMAB is generally used to treat: Melanoma, Kidney Cancer

Frequently Asked Questions

Q: Is it safe on my liver?
A: Not Safe

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Not Advised for age < 12yrs

Q: Can it be taken during pregnancy?
A: Not enough studies to prove Risk – Ask your Doctor

How Do I Take It?

Route of Administration: IV (Intravenous)

Precautions

Caution should be exercised in patients with history of autoimmune disease, liver impairment, any allergy, who are taking other medications, children, during pregnancy and breastfeeding. Monitor liver and thyroid functions regularly while taking this medication. Avoid excess dosage.

Symptoms of Overdosage

IPILIMUMAB over-dosage can result in: Difficulty Breathing

Common Side-Effects

IPILIMUMAB : Depression, Hives, Bloody Or Red Colored Stools, Black (tar) Colored Stools, Loose Motion, Fever, Heartburn, Body Itching, Nausea, Vomit, Weakness (generalized), Fatigue (tiredness), Head Headache, Dizziness, Eyes Pain, Throat Soreness

Rare Side-Effects

IPILIMUMAB : Anxiety, Chest Pain, Confusion, Constipation, Rapid Heart Rate (pulse)

Disease Interactions

IPILIMUMAB can interfere with: Allergy, Dermatitis Herpetiformis, Hypothyroidism, Adrenal Insufficiency, Hyperthyroidism, Diarrhoea, Enterocolitis, Gastroenteritis, Inflammatory Bowel Disease, Autonomic Dysfunction (Autonomic Nervous System Diseases), Guillan-Barre Syndrome

Technical Classification

IPILIMUMAB is categorized as: ANTI-CTLA-4 MONOCLONAL ANTIBODIES / ANTINEOPLASTICS

Storage Conditions

Refrigeration (Between 2 To 8 C)

Available Alternatives

What are the other drugs with similar Ingredients?

IPILIMUMABIPILIMUMAB